<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01001481</url>
  </required_header>
  <id_info>
    <org_study_id>CR013822</org_study_id>
    <nct_id>NCT01001481</nct_id>
  </id_info>
  <brief_title>Schizophrenia Treatment Adherence Investigation (STAI)</brief_title>
  <official_title>Clinical Audit and Feedback Program to Determine Risk for Medication Adherence in Outpatients Diagnosed With Schizophrenia in Australia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Janssen-Cilag Pty Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Janssen-Cilag Pty Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this treatment review and feedback program is to quantify the risk
      status for medication adherence in a cohort of Australian patients diagnosed with
      schizophrenia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this treatment review and feedback program is to quantify the risk
      status for medication adherence in a cohort of Australian patients diagnosed with
      schizophrenia. Observational study - no study drug administered
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome measure is the Clinical Assessment of Adherence as rated by the Investigators</measure>
    <time_frame>6 months, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical exacerbations (worsening of symptoms)</measure>
    <time_frame>6 mths, 12 mths</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication changes</measure>
    <time_frame>6 mths, 12 mths</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">550</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <arm_group>
    <arm_group_label>001</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Risk status for medication adherence</intervention_name>
    <description>Examination of risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia</description>
    <arm_group_label>001</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV

          -  Currently treated in an outpatient clinic

          -  Able to provide informed consent

          -  Concurrent enrolment in clinical trials is acceptable

          -  Have completed all questions on the Drug Attitude Inventory (DAI-10) and Medication
             Adherence Rating Scale (MARS) survey

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janssen-Cilag Pty Ltd Clinical Trial</last_name>
    <role>Study Director</role>
    <affiliation>Janssen-Cilag Pty Ltd</affiliation>
  </overall_official>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2009</study_first_submitted>
  <study_first_submitted_qc>October 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2009</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Treatment review</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>Observational</keyword>
  <keyword>Prospective studies</keyword>
  <keyword>Australia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

